Results: 2

Figure 2

Figure 2. From: A Randomized, Controlled Trial of Panax quinquefolius extract (CVT-E002) to Reduce Respiratory Infection in Patients with Chronic Lymphocytic Leukemia.

Respiratory illness symptoms reported as moderate-severe. The percent of subjects in each group reporting moderate-severe acute respiratory illness symptoms (worst reported severity Jan-Mar) is shown.

Kevin P. High, et al. J Support Oncol. ;10(5):195-201.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk